Table 1. Retrotransposons reported as dysregulated in brain, cerebrospinal fluid (CSF) or plasma from patients with neurodegenerative disorders.
Disease | Increased | Decreased | ||
---|---|---|---|---|
Transposable Element | Subfamily | Transposable Element | Subfamily | |
Alzheimer’s Disease (AD) | ERV | ERV17, ERV9, ERVH48I, ERVK22I, ERVKC4, ERVL
[11] ERVFc_1 [46] |
||
LINE1 | L1PA7_5 [11] L1MB4_5 [46] |
|||
LTR | LTR12C, LTR14 [11] LTR77, PRIMA4_LTR [46] |
|||
SINE | AluYh9, AluYc5, AluSp [46] | SINE | AluYa5, AluYb8, AluYc1, AluYi6 [10] | |
Other | SVA_B, SVA_C, TIGGER2 [11] THER2, PB1D11 [46] |
|||
Progressive Supranuclear Palsy (PSP) | ERV | ERV17, ERV9, ERVH48I, ERVK22I, ERVKC4, ERVL, ERVH, ERVP71A_I [11] | ||
LINE1 | L1PB2c [11] | |||
LTR | LTR12C, LTR14 [11] | LTR14A [10] | ||
SINE | AluYa5, AluYb8, AluYc1, AluYi6, AluSp, AluY, AluYd8, AluYe5, AluYg6, AluYk11, AluYk12 [10] | |||
Amyotrophic Lateral Sclerosis (ALS) | ERV | ERVK pol and RT protein
[30] ERV-K gag, pol, env transcripts and env protein [18] |
||
LINE1 | L1MA9 [40] | |||
LTR | LTR2, LTR70, MER21B, MER51C [40] | |||
SINE | AluYk12, AluYa5, FRAM [40] | |||
Other | Reverse transcriptase activity [27–29] | |||
Frontotemporal lobar degeneration (FTD) | LINE1 | L1MA9 [40] | ||
LTR | LTR2, LTR70, MER21B, MER51C [40] | |||
SINE | AluYk12, AluYa5, FRAM [40] | |||
Sporadic Creutzfeldt-Jakob Disease (sCJD) | ERV | ERV-W, ERV-T, ERV-FRD, ERV- L, ERV-9 [56] |